Phase II evaluation of the AMAP, 773U82 mesylate, in pancreatic cancer Donald L. TrumpJames A. HathornJohn A. Hohneker OriginalPaper Pages: 273 - 276
Phase I study of mitonafide with a 3-day administration schedule: Early interruption due to severe central nervous system toxicity Eduardo Díaz-RubioMiguel MartínAna Benavides OriginalPaper Pages: 277 - 281
Phase I/II trial of dipyridamole, 5-fluorouracil, leukovorin, and mitoxantrone in metastatic breast cancer G. Thomas BuddPamela HerzogRonald M. Bukowski OriginalPaper Pages: 283 - 287
Postincubation with aclarubicin reverses topoisomerase II mediated DNA cleavage, strand breaks, and cytotoxicity induced by VP-16 Lone Nørgård PetersenPeter Buhl JensenMogens Spang-Thomsen OriginalPaper Pages: 289 - 297
High-dose aminothiadiazole in advanced colorectal cancer Gershon Y. LockerLary KiltonAl. B. Benson III OriginalPaper Pages: 299 - 301
Pharmaceutical development of a parenteral formulation of the novel anti-tumor agent carzelesin (U-80,244) Jantine D. Jonkman de VriesMarga J. A. de Graaff-TeulenJos H. Beijnen OriginalPaper Pages: 303 - 314
Phase II study of elsamitrucin in non-small cell lung cancer Glenwood GossFrançois LetendreElizabeth Eisenhauer Brief Report Pages: 315 - 317
Phase II trial of PALA and 6-methylmercaptopurine riboside (MMPR) in combination with 5-fluorouracil in advanced pancreatic cancer Istvan RedeiFran GreenPeter J. O'Dwyer OriginalPaper Pages: 319 - 321
Phase II trial of liposomal encapsulated doxorubicin in patients with advanced renal cell carcinoma Teresa Murray LawPeter MencelRobert J. Motzer Brief Report Pages: 323 - 325
Phase II study of carboplatin and edatrexate (10-EdAM) with leucovorin rescue for patients with recurrent squamous cell carcinoma of the head and neck Martin H. HuberIsaiah W. DimeryWaun Ki Hong OriginalPaper Pages: 327 - 331
Phase II trial of piroxantrone in metastatic breast cancer Peter M. RavdinStephanie GreenSilvana Martino OriginalPaper Pages: 333 - 336
Hepatoma/merbarone Elizabeth A. PoplinCatherine M. TangenJohn S. Macdonald OriginalPaper Pages: 337 - 340
Phase II study of edatrexate in advanced head and neck cancer J. Philip KueblerJacqueline BenedettiManly E. Marshall OriginalPaper Pages: 341 - 344
Phase II trial of 6-thioguanine in advanced renal cell carcinoma Daniel H. ShevrinLary J. KiltonAl. B. Benson III OriginalPaper Pages: 345 - 346